• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Walgreens Study: Pill Reminder, Activity Tracking Features Improves Medication Adherance

by HITC Staff 09/13/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

walgreens-digital-health

Walgreens mobile pill reminder feature and its activity tracking digital health solutions has improved medication adherence among pharmacy patients, according to two recent company studies. Recent Walgreens research has shown that consumers over 50 years of age who track activities through its Balance® Rewards for healthy choices (BRhc) program, which awards loyalty points for healthy behaviors and activities, are more adherent to their medication therapies. A separate Walgreens study found that the pill reminder feature within the Walgreens mobile app is also demonstrating better optimal adherence[1] among users. 

Balance Rewards for healthy choices and patients over 50 Study

The Walgreens retrospective cohort study examined patients who filled an antihypertensive, oral antidiabetic or antihyperlipidemic medication among those 50 years old or greater, between March and October 2014. The findings concluded that tracking physical activity four or more times per week were 11.2 percent higher for antihypertensives, 5.1 percent higher for oral antidiabetics and 4.5 percent higher for antihyperlipidemics. 

[2] In addition, tracking blood pressure twice or more per week or tracking blood glucose once or more per week was associated with significantly better optimal adherence: 6.8 percent higher for patients taking antihypertensives and 12.3 percent higher for oral antidiabetics.

Mobile Pill Reminder Research Findings

For the mobile pill reminder feature, the Walgreens study took a group comprised of patients who used the pill reminder and had oral antidiabetic, antihypertensive or antihyperlipidemic medications between an index period of January 2014 and September 2014 and compared to a control group comprised of those who did not use the pill reminder.

The research found that utilization of the Walgreens mobile app pill reminder was 12.3 percent higher for oral antidiabetics, 11.3 percent higher for antihypertensives and 9.1 percent higher for antihyperlipidemics.

References

[1]  Defined as having PDC (Proportion of Days Covered) >= 80%.  PDC is a PQA (Pharmacy Quality Alliance) recommended metric for estimating medication adherence and PQA selected PDC >=80% to be considered as highly-adherent.
[2] Akinbosoye O, Taylor D, Jiang J, Taitel M, Orr G. The Relationship Between Digital Health Program Activity Tracking and Medication Adherence Among Members Age 50+ years. JMCP APRIL 2016 Vol. 22, No.4-a S44
[3] Akinbosoye O, Jiang J, Taitel M, Orr G ‘The Association between Use of a Community Pharmacy’s Mobile Pill Reminder App and Medication Adherence’ Presented at the Society of Behavioral Medicine 37th Annual Meeting, March 30- April 2, 2016, Washington DC.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Medication Adherance, Walgreens

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |